Edition:
United Kingdom

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

47.30USD
22 Jun 2018
Change (% chg)

$0.10 (+0.21%)
Prev Close
$47.20
Open
$47.25
Day's High
$47.55
Day's Low
$46.85
Volume
184,906
Avg. Vol
60,439
52-wk High
$62.25
52-wk Low
$42.55

Chart for

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $1,842.68
Shares Outstanding(Mil.): 32.73
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 19.11 30.95 32.74
EPS (TTM): 2.95 -- --
ROI: 18.81 14.84 14.38
ROE: 23.78 16.34 16.08

BRIEF-Cambrex Q1 EPS $0.32 From Continuing Operations

* Q1 EARNINGS PER SHARE $0.32 FROM CONTINUING OPERATIONS EXCLUDING ITEMS

03 May 2018

BRIEF-Cambrex Reports Q4 Adj. Earnings Per Share $1.27 From Continuing Operations

* CAMBREX REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

08 Feb 2018

BRIEF-Cambrex Announces Investment At Its Charles City, Iowa Plant

* CAMBREX CORP - ANNOUNCED AN INVESTMENT TO EXPAND CHEMICAL AND ANALYTICAL DEVELOPMENT CAPABILITIES AT ITS CHARLES CITY, IOWA PLANT

30 Jan 2018

BRIEF-Cambrex & Astrazeneca Hold Ceremony To Mark Long-Term Supply Agreement At Karlskoga, Sweden Facility

* CAMBREX & ASTRAZENECA HOLD CEREMONY TO MARK LONG-TERM SUPPLY AGREEMENT AT KARLSKOGA, SWEDEN FACILITY Source text for Eikon: Further company coverage:

16 Jan 2018

Earnings vs. Estimates